Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06097871 · ClinicalTrials.gov registry record · NA
RCT of an Oral Acne Supplement for Adult Women
A NA study of Acne, sponsored by Nutraceutical Wellness.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT06097871: Completed NA study of Acne, sponsored by Nutraceutical Wellness.
NCT06097871 is a NA study of Acne that has completed, run by Nutraceutical Wellness. The registered enrollment target is 102 participants, below the 139-participant average among 26 other Acne trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06097871, a NA study of Acne, has completed, sponsored by Nutraceutical Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to assess the efficacy and tolerability of an oral supplement in mild to moderate acne in adult females.
Primary Outcome
The primary efficacy endpoint is the investigator assessed change from baseline to week 12 in facial acne IGA rating compared to placebo.
Conditions Studied
Interventions
- OTHER Placebo pill
- DIETARY_SUPPLEMENT Skin Nutraceutical Supplement
Study Locations (1)
North Carolina
- Dermatology Consulting Services - High Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2024-07-25 |
| Phase | NA |
What the finished NCT06097871 record still lists
NCT06097871 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 139-participant average among 26 other Acne trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 2 interventions - of which Placebo pill is the first listed.
NCT06097871 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06097871 about?
NCT06097871 is a clinical study titled "RCT of an Oral Acne Supplement for Adult Women". This study is to assess the efficacy and tolerability of an oral supplement in mild to moderate acne in adult females.
What is the current status of trial NCT06097871?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2024-01-15. Estimated completion is 2024-07-25.
What conditions does trial NCT06097871 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT06097871?
The interventions under investigation include: Placebo pill (OTHER), Skin Nutraceutical Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06097871?
This trial is sponsored by Nutraceutical Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06097871 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06097871's enrollment target sits among peer trials
102 11th of 26 higher than 16 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI